Literature DB >> 29032985

DAMP-TLR-cytokine axis dictates the fate of tumor.

Ashok Patidar1, Sathishkumar Selvaraj1, Aditya Sarode1, Prashant Chauhan1, Debprasad Chattopadhyay2, Bhaskar Saha3.   

Abstract

Random mutations leading to loss of cell cycle control is not a rare occurrence in an organism but the mutated cells are recognized and eliminated preventing the development of a tumor. These potentially tumorigenic cells release damage-associated molecular patterns (DAMPs), which are recognized by toll-like receptors (TLRs) on macrophages and dendritic cells. The initial TLR-DAMP interactions lead to different responses such as altered antigen presentation and cytokine release that directly affect T cell activation and removal of the tumorigenic cells. The indirect effects of TLR-DAMP interaction include chemokine-directed altered T cell trafficking, angiogenesis for both T cell infiltration and tumor cell metastasis, and alteration of intra-tumoral milieu contributing to the development of tumor cells heterogeneity. Thus, the initial TLR-DAMP interaction has a set of local effects that modulate tumor cell growth and heterogeneity and a disseminating set of central effects that dynamically affect T cell trafficking and functions. Herein, we argue that the DAMP-TLR-cytokine axis in the tumor microenvironment serves as the mainstay that orchestrates and regulates the pro- and anti-tumor elements which dynamically interact between themselves eventuating in tumor regression or growth. The knowledge of this TLR-based immuno-surveillance framework is a key to developing a novel immunotherapy against cancer.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cytokines; DAMPs; T cell trafficking; Toll-like receptors; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 29032985     DOI: 10.1016/j.cyto.2017.10.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  25 in total

Review 1.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

2.  Peptidoglycan-treated tumor antigen-pulsed dendritic cells impart complete resistance against tumor rechallenge.

Authors:  A Patidar; S Selvaraj; P Chauhan; C A Guzman; T Ebensen; A Sarkar; D Chattopadhyay; B Saha
Journal:  Clin Exp Immunol       Date:  2020-06-26       Impact factor: 4.330

Review 3.  Trial watch: dendritic cell vaccination for cancer immunotherapy.

Authors:  Jenny Sprooten; Jolien Ceusters; An Coosemans; Patrizia Agostinis; Steven De Vleeschouwer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2019-07-18       Impact factor: 8.110

Review 4.  Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019.

Authors:  Jiayu Dai; Yibo Wang; Hongrui Wang; Ziyuan Gao; Ying Wang; Mingli Fang; Shuyou Shi; Peng Zhang; Hua Wang; Yingying Su; Ming Yang
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

Review 5.  TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer.

Authors:  Aina Martín-Medina; Noemi Cerón-Pisa; Esther Martinez-Font; Hanaa Shafiek; Antònia Obrador-Hevia; Jaume Sauleda; Amanda Iglesias
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

6.  How Oncogenic Viruses Exploit p62-Mediated Selective Autophagy for Cancer Development.

Authors:  Shunbin Ning; Ling Wang
Journal:  Ann Immunol Immunother       Date:  2021-03-05

Review 7.  Stress and cancer: mechanisms, significance and future directions.

Authors:  Anabel Eckerling; Itay Ricon-Becker; Liat Sorski; Elad Sandbank; Shamgar Ben-Eliyahu
Journal:  Nat Rev Cancer       Date:  2021-09-10       Impact factor: 60.716

Review 8.  B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.

Authors:  Yuan Wei; Chun-Xiang Huang; Xiao Xiao; Dong-Ping Chen; Hong Shan; Huanhuan He; Dong-Ming Kuang
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

9.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

10.  Intestinal microbiome adjusts the innate immune setpoint during colonization through negative regulation of MyD88.

Authors:  Bjørn E V Koch; Shuxin Yang; Gerda Lamers; Jens Stougaard; Herman P Spaink
Journal:  Nat Commun       Date:  2018-10-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.